Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dai Fukumura, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Dai Fukumura and Rakesh Jain.
Connection Strength

27.228
  1. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat Rev Clin Oncol. 2018 05; 15(5):325-340.
    View in: PubMed
    Score: 0.751
  2. Obesity and Cancer: An Angiogenic and Inflammatory Link. Microcirculation. 2016 Apr; 23(3):191-206.
    View in: PubMed
    Score: 0.657
  3. Measuring interstitial pH and pO2 in mouse tumors. Cold Spring Harb Protoc. 2013 Jul 01; 2013(7):675-7.
    View in: PubMed
    Score: 0.543
  4. Measuring interstitial diffusion, convection, and binding parameters in mouse tumors. Cold Spring Harb Protoc. 2013 Jul 01; 2013(7):678-80.
    View in: PubMed
    Score: 0.543
  5. Measuring leukocyte-endothelial interactions in mice. Cold Spring Harb Protoc. 2013 Jun 01; 2013(6):561-3.
    View in: PubMed
    Score: 0.540
  6. Measuring vascular permeability in mice. Cold Spring Harb Protoc. 2013 May 01; 2013(5):444-6.
    View in: PubMed
    Score: 0.537
  7. Measuring angiogenesis and hemodynamics in mice. Cold Spring Harb Protoc. 2013 Apr 01; 2013(4):354-8.
    View in: PubMed
    Score: 0.533
  8. Lung window preparation in mice. Cold Spring Harb Protoc. 2013 Jan 01; 2013(1).
    View in: PubMed
    Score: 0.524
  9. Pancreatic tumor preparation in mice. Cold Spring Harb Protoc. 2012 Dec 01; 2012(12).
    View in: PubMed
    Score: 0.521
  10. Liver tumor preparation in mice. Cold Spring Harb Protoc. 2012 Dec 01; 2012(12).
    View in: PubMed
    Score: 0.521
  11. Lymphangiography of the mouse tail. Cold Spring Harb Protoc. 2012 Nov 01; 2012(11):1177-8.
    View in: PubMed
    Score: 0.518
  12. Lymphangiography of the mouse ear. Cold Spring Harb Protoc. 2012 Nov 01; 2012(11):1179-80.
    View in: PubMed
    Score: 0.518
  13. Mammary fat pad chamber preparation in mice. Cold Spring Harb Protoc. 2012 Oct 01; 2012(10):1113-4.
    View in: PubMed
    Score: 0.515
  14. Mammary fat pad tumor preparation in mice. Cold Spring Harb Protoc. 2012 Oct 01; 2012(10):1115-6.
    View in: PubMed
    Score: 0.515
  15. Corneal pocket assay in rabbits. Cold Spring Harb Protoc. 2012 Sep 01; 2012(9):1017-8.
    View in: PubMed
    Score: 0.512
  16. Rabbit ear chambers. Cold Spring Harb Protoc. 2012 Jul 01; 2012(7):813-14.
    View in: PubMed
    Score: 0.506
  17. Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models. Microcirculation. 2010 Apr; 17(3):206-25.
    View in: PubMed
    Score: 0.433
  18. Imaging angiogenesis and the microenvironment. APMIS. 2008 Jul-Aug; 116(7-8):695-715.
    View in: PubMed
    Score: 0.384
  19. Targeting PDGF signaling in carcinoma-associated fibroblasts controls cervical cancer in mouse model. PLoS Med. 2008 Jan 29; 5(1):e24.
    View in: PubMed
    Score: 0.373
  20. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem. 2007 Jul 01; 101(4):937-49.
    View in: PubMed
    Score: 0.358
  21. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res. 2007 Sep-Nov; 74(2-3):72-84.
    View in: PubMed
    Score: 0.355
  22. The role of nitric oxide in tumour progression. Nat Rev Cancer. 2006 Jul; 6(7):521-34.
    View in: PubMed
    Score: 0.334
  23. Engineering vascularized tissue. Nat Biotechnol. 2005 Jul; 23(7):821-3.
    View in: PubMed
    Score: 0.312
  24. Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res. 2003 Oct 31; 93(9):e88-97.
    View in: PubMed
    Score: 0.276
  25. Dissecting tumour pathophysiology using intravital microscopy. Nat Rev Cancer. 2002 Apr; 2(4):266-76.
    View in: PubMed
    Score: 0.249
  26. Dendritic cell paucity in mismatch repair-proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy. Proc Natl Acad Sci U S A. 2021 11 09; 118(45).
    View in: PubMed
    Score: 0.242
  27. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res. 2001 Aug 15; 61(16):6020-4.
    View in: PubMed
    Score: 0.238
  28. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Nat Commun. 2021 05 11; 12(1):2582.
    View in: PubMed
    Score: 0.234
  29. Exercise Training Improves Tumor Control by Increasing CD8+ T-cell Infiltration via CXCR3 Signaling and Sensitizes Breast Cancer to Immune Checkpoint Blockade. Cancer Immunol Res. 2021 07; 9(7):765-778.
    View in: PubMed
    Score: 0.233
  30. Implications of a granulocyte-high glioblastoma microenvironment in immune suppression and therapy resistance†. J Pathol. 2021 06; 254(2):105-108.
    View in: PubMed
    Score: 0.232
  31. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A. 2001 Feb 27; 98(5):2604-9.
    View in: PubMed
    Score: 0.231
  32. Experimental and computational analyses reveal dynamics of tumor vessel cooption and optimal treatment strategies. Proc Natl Acad Sci U S A. 2019 02 12; 116(7):2662-2671.
    View in: PubMed
    Score: 0.200
  33. Dual endothelin receptor inhibition enhances T-DM1 efficacy in brain metastases from HER2-positive breast cancer. NPJ Breast Cancer. 2019; 5:4.
    View in: PubMed
    Score: 0.199
  34. Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium. Nat Biomed Eng. 2019 03; 3(3):230-245.
    View in: PubMed
    Score: 0.199
  35. Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption. Proc Natl Acad Sci U S A. 2018 09 11; 115(37):E8717-E8726.
    View in: PubMed
    Score: 0.194
  36. Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2. Sci Transl Med. 2018 03 14; 10(432).
    View in: PubMed
    Score: 0.188
  37. Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev. 1998 Mar; 17(1):77-89.
    View in: PubMed
    Score: 0.187
  38. A cerebellar window for intravital imaging of normal and disease states in mice. Nat Protoc. 2017 Nov; 12(11):2251-2262.
    View in: PubMed
    Score: 0.182
  39. Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancer. Proc Natl Acad Sci U S A. 2017 09 26; 114(39):10455-10460.
    View in: PubMed
    Score: 0.182
  40. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol. 1997 Sep; 151(3):679-88.
    View in: PubMed
    Score: 0.181
  41. Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy. J Clin Invest. 2017 Aug 01; 127(8):3039-3051.
    View in: PubMed
    Score: 0.179
  42. The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation. Sci Transl Med. 2017 05 24; 9(391).
    View in: PubMed
    Score: 0.178
  43. Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. Am J Pathol. 1997 Feb; 150(2):713-25.
    View in: PubMed
    Score: 0.174
  44. Corrigendum: Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity. Cold Spring Harb Perspect Med. 2016 12 01; 6(12).
    View in: PubMed
    Score: 0.172
  45. Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity. Cold Spring Harb Perspect Med. 2016 Dec 01; 6(12).
    View in: PubMed
    Score: 0.172
  46. Solid stress and elastic energy as measures of tumour mechanopathology. Nat Biomed Eng. 2016; 1.
    View in: PubMed
    Score: 0.172
  47. Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases. Sci Transl Med. 2016 10 12; 8(360):360ra135.
    View in: PubMed
    Score: 0.170
  48. Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy. Cancer Discov. 2016 08; 6(8):852-69.
    View in: PubMed
    Score: 0.166
  49. Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages. Proc Natl Acad Sci U S A. 2016 Apr 19; 113(16):4470-5.
    View in: PubMed
    Score: 0.164
  50. Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival. Proc Natl Acad Sci U S A. 2016 Apr 19; 113(16):4476-81.
    View in: PubMed
    Score: 0.164
  51. PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity. Clin Cancer Res. 2016 06 15; 22(12):2993-3004.
    View in: PubMed
    Score: 0.163
  52. Mast Cells Contribute to Radiation-Induced Vascular Hyperpermeability. Radiat Res. 2016 Feb; 185(2):182-9.
    View in: PubMed
    Score: 0.162
  53. Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages. PLoS One. 2015; 10(12):e0141392.
    View in: PubMed
    Score: 0.161
  54. Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment. J Natl Cancer Inst. 2016 Feb; 108(2).
    View in: PubMed
    Score: 0.160
  55. Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. Cancer Res. 1995 Nov 01; 55(21):4824-9.
    View in: PubMed
    Score: 0.160
  56. Vascular diseases await translation of blood vessels engineered from stem cells. Sci Transl Med. 2015 Oct 14; 7(309):309rv6.
    View in: PubMed
    Score: 0.159
  57. From the Guest Editors: Role of Tumor Microenvironment in Tumor Progression and Treatment Response: A 30 Years' Journey. Cancer J. 2015 Jul-Aug; 21(4):235-6.
    View in: PubMed
    Score: 0.156
  58. Lessons From 30 Years of Teaching About the Microenvironment of Tumors. Cancer J. 2015 May-Jun; 21(3):137.
    View in: PubMed
    Score: 0.154
  59. Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy. J Natl Cancer Inst. 2015 Apr; 107(4).
    View in: PubMed
    Score: 0.152
  60. Towards Optimal Design of Cancer Nanomedicines: Multi-stage Nanoparticles for the Treatment of Solid Tumors. Ann Biomed Eng. 2015 Sep; 43(9):2291-300.
    View in: PubMed
    Score: 0.152
  61. Emerging strategies for treating brain metastases from breast cancer. Cancer Cell. 2015 Feb 09; 27(2):163-75.
    View in: PubMed
    Score: 0.152
  62. Benefits of vascular normalization are dose and time dependent--letter. Cancer Res. 2013 Dec 01; 73(23):7144-6.
    View in: PubMed
    Score: 0.139
  63. Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression. J Natl Cancer Inst. 2013 Aug 21; 105(16):1188-201.
    View in: PubMed
    Score: 0.136
  64. Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2013 Jul 30; 110(31):12774-9.
    View in: PubMed
    Score: 0.136
  65. Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma. Cell. 2013 Feb 28; 152(5):1065-76.
    View in: PubMed
    Score: 0.133
  66. Vascular normalization as an emerging strategy to enhance cancer immunotherapy. Cancer Res. 2013 May 15; 73(10):2943-8.
    View in: PubMed
    Score: 0.132
  67. Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases. Proc Natl Acad Sci U S A. 2012 Nov 06; 109(45):E3119-27.
    View in: PubMed
    Score: 0.129
  68. Cationic nanoparticles have superior transvascular flux into solid tumors: insights from a mathematical model. Ann Biomed Eng. 2013 Jan; 41(1):68-77.
    View in: PubMed
    Score: 0.127
  69. Normalization of the tumor vasculature through oncogenic inhibition: an emerging paradigm in tumor biology. Proc Natl Acad Sci U S A. 2012 May 15; 109(20):E1214.
    View in: PubMed
    Score: 0.125
  70. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat Nanotechnol. 2012 Apr 08; 7(6):383-8.
    View in: PubMed
    Score: 0.125
  71. A transient parabiosis skin transplantation model in mice. Nat Protoc. 2012 Mar 22; 7(4):763-70.
    View in: PubMed
    Score: 0.124
  72. An isolated tumor perfusion model in mice. Nat Protoc. 2012 Mar 22; 7(4):749-55.
    View in: PubMed
    Score: 0.124
  73. Multistage nanoparticles for improved delivery into tumor tissue. Methods Enzymol. 2012; 508:109-30.
    View in: PubMed
    Score: 0.122
  74. Video-rate resonant scanning multiphoton microscopy: An emerging technique for intravital imaging of the tumor microenvironment. Intravital. 2012; 1(1).
    View in: PubMed
    Score: 0.122
  75. Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration. Angew Chem Int Ed Engl. 2011 Nov 25; 50(48):11417-20.
    View in: PubMed
    Score: 0.120
  76. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev. 2011 Jul; 91(3):1071-121.
    View in: PubMed
    Score: 0.118
  77. Spontaneous nonthymic tumors in SCID mice. Comp Med. 2011 Jun; 61(3):227-34.
    View in: PubMed
    Score: 0.117
  78. The biology of brain metastases-translation to new therapies. Nat Rev Clin Oncol. 2011 Jun; 8(6):344-56.
    View in: PubMed
    Score: 0.116
  79. CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies? Clin Cancer Res. 2011 Apr 15; 17(8):2074-80.
    View in: PubMed
    Score: 0.115
  80. Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation. Proc Natl Acad Sci U S A. 2011 Mar 01; 108(9):3725-30.
    View in: PubMed
    Score: 0.115
  81. Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci U S A. 2011 Feb 08; 108(6):2426-31.
    View in: PubMed
    Score: 0.114
  82. Scaling rules for diffusive drug delivery in tumor and normal tissues. Proc Natl Acad Sci U S A. 2011 Feb 01; 108(5):1799-803.
    View in: PubMed
    Score: 0.114
  83. C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells. Proc Natl Acad Sci U S A. 2011 Jan 04; 108(1):302-7.
    View in: PubMed
    Score: 0.114
  84. Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci U S A. 2010 Dec 14; 107(50):21677-82.
    View in: PubMed
    Score: 0.113
  85. Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions. Biophys J. 2010 Sep 08; 99(5):1342-9.
    View in: PubMed
    Score: 0.112
  86. In vivo imaging of tumors. Cold Spring Harb Protoc. 2010 Jul 01; 2010(7):pdb.prot5452.
    View in: PubMed
    Score: 0.110
  87. Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas. Clin Cancer Res. 2010 Jul 15; 16(14):3618-27.
    View in: PubMed
    Score: 0.109
  88. Optical methods in vascular biology and medicine. J Biomed Opt. 2010 Jan-Feb; 15(1):011001.
    View in: PubMed
    Score: 0.106
  89. Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases. PLoS One. 2009 Dec 15; 4(12):e8316.
    View in: PubMed
    Score: 0.106
  90. VEGFR1 activity modulates myeloid cell infiltration in growing lung metastases but is not required for spontaneous metastasis formation. PLoS One. 2009 Sep 18; 4(9):e6525.
    View in: PubMed
    Score: 0.104
  91. VEGFR1-activity-independent metastasis formation. Nature. 2009 Sep 17; 461(7262):E4; discussion E5.
    View in: PubMed
    Score: 0.104
  92. Paradoxical effects of PDGF-BB overexpression in endothelial cells on engineered blood vessels in vivo. Am J Pathol. 2009 Jul; 175(1):294-302.
    View in: PubMed
    Score: 0.102
  93. Lack of lymphatic vessel phenotype in LYVE-1/CD44 double knockout mice. J Cell Physiol. 2009 May; 219(2):430-7.
    View in: PubMed
    Score: 0.102
  94. Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells. PLoS One. 2009; 4(3):e4974.
    View in: PubMed
    Score: 0.101
  95. Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice. J Clin Oncol. 2009 May 20; 27(15):2542-52.
    View in: PubMed
    Score: 0.101
  96. Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis. Cancer Res. 2009 Apr 01; 69(7):2801-8.
    View in: PubMed
    Score: 0.101
  97. A mathematical model of murine metabolic regulation by leptin: energy balance and defense of a stable body weight. Cell Metab. 2009 Jan 07; 9(1):52-63.
    View in: PubMed
    Score: 0.099
  98. Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib. Mol Cancer Ther. 2008 Aug; 7(8):2272-9.
    View in: PubMed
    Score: 0.097
  99. Histopathologic findings and establishment of novel tumor lines from spontaneous tumors in FVB/N mice. Comp Med. 2008 Jun; 58(3):253-63.
    View in: PubMed
    Score: 0.095
  100. Perivascular nitric oxide gradients normalize tumor vasculature. Nat Med. 2008 Mar; 14(3):255-7.
    View in: PubMed
    Score: 0.094
  101. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood. 2008 May 01; 111(9):4551-8.
    View in: PubMed
    Score: 0.093
  102. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood. 2008 Feb 01; 111(3):1302-5.
    View in: PubMed
    Score: 0.092
  103. Anti-VEGFR-3 therapy and lymph node metastasis [corrected]. Cancer Res. 2007 May 15; 67(10):5055; author reply 5056.
    View in: PubMed
    Score: 0.089
  104. Small blood vessel engineering. Methods Mol Med. 2007; 140:183-95.
    View in: PubMed
    Score: 0.086
  105. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res. 2006 Aug 15; 66(16):8065-75.
    View in: PubMed
    Score: 0.084
  106. Evolution of oxygen and glucose concentration profiles in a tissue-mimetic culture system of embryonic stem cells. Ann Biomed Eng. 2006 Aug; 34(8):1247-58.
    View in: PubMed
    Score: 0.084
  107. Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models. Cancer Res. 2006 Apr 15; 66(8):3971-7.
    View in: PubMed
    Score: 0.082
  108. Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis. Cancer Res. 2006 Apr 01; 66(7):3360-4.
    View in: PubMed
    Score: 0.082
  109. Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. Blood. 2006 Apr 01; 107(7):2774-6.
    View in: PubMed
    Score: 0.080
  110. Molecular regulation of microlymphatic formation and function: role of nitric oxide. Trends Cardiovasc Med. 2005 Jul; 15(5):169-73.
    View in: PubMed
    Score: 0.078
  111. NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels. J Clin Invest. 2005 Jul; 115(7):1816-27.
    View in: PubMed
    Score: 0.078
  112. Green fluorescent protein (GFP)-expressing tumor model derived from a spontaneous osteosarcoma in a vascular endothelial growth factor (VEGF)-GFP transgenic mouse. Comp Med. 2005 Jun; 55(3):236-43.
    View in: PubMed
    Score: 0.077
  113. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nat Med. 2005 Jun; 11(6):678-82.
    View in: PubMed
    Score: 0.077
  114. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell. 2004 Dec; 6(6):553-63.
    View in: PubMed
    Score: 0.075
  115. Differential transplantability of tumor-associated stromal cells. Cancer Res. 2004 Sep 01; 64(17):5920-4.
    View in: PubMed
    Score: 0.074
  116. Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function. Cancer Res. 2004 Jul 01; 64(13):4400-4.
    View in: PubMed
    Score: 0.073
  117. Endothelial nitric oxide synthase regulates microlymphatic flow via collecting lymphatics. Circ Res. 2004 Jul 23; 95(2):204-9.
    View in: PubMed
    Score: 0.072
  118. Role of eNOS in neovascularization: NO for endothelial progenitor cells. Trends Mol Med. 2004 Apr; 10(4):143-5.
    View in: PubMed
    Score: 0.071
  119. Influence of the site of human gallbladder xenograft (Mz-ChA-1) on angiogenesis at the distant site. Oncol Rep. 2004 Apr; 11(4):803-7.
    View in: PubMed
    Score: 0.071
  120. Tissue engineering: creation of long-lasting blood vessels. Nature. 2004 Mar 11; 428(6979):138-9.
    View in: PubMed
    Score: 0.071
  121. Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors. Cancer Res. 2003 Sep 01; 63(17):5188-93.
    View in: PubMed
    Score: 0.069
  122. Photodynamic therapy for cancer. Nat Rev Cancer. 2003 May; 3(5):380-7.
    View in: PubMed
    Score: 0.067
  123. Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy. Cancer Res. 2002 Aug 01; 62(15):4289-94.
    View in: PubMed
    Score: 0.064
  124. Vascular accumulation of a novel photosensitizer, MV6401, causes selective thrombosis in tumor vessels after photodynamic therapy. Cancer Res. 2002 Apr 01; 62(7):2151-6.
    View in: PubMed
    Score: 0.062
  125. Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. Clin Cancer Res. 2002 Apr; 8(4):1008-13.
    View in: PubMed
    Score: 0.062
  126. Gabrb3 endothelial cell-specific knockout mice display abnormal blood flow, hypertension, and behavioral dysfunction. Sci Rep. 2022 Mar 22; 12(1):4922.
    View in: PubMed
    Score: 0.062
  127. Tumour biology: herceptin acts as an anti-angiogenic cocktail. Nature. 2002 Mar 21; 416(6878):279-80.
    View in: PubMed
    Score: 0.062
  128. Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway: mechanism of low pH-induced VEGF. J Biol Chem. 2002 Mar 29; 277(13):11368-74.
    View in: PubMed
    Score: 0.061
  129. Author Correction: Fatty acid synthesis is required for breast cancer brain metastasis. Nat Cancer. 2021 Nov; 2(11):1243.
    View in: PubMed
    Score: 0.060
  130. Pancreas microenvironment promotes VEGF expression and tumor growth: novel window models for pancreatic tumor angiogenesis and microcirculation. Lab Invest. 2001 Oct; 81(10):1439-51.
    View in: PubMed
    Score: 0.060
  131. In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med. 2001 Jul; 7(7):864-8.
    View in: PubMed
    Score: 0.059
  132. FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASIS. Nat Cancer. 2021 Apr; 2(4):414-428.
    View in: PubMed
    Score: 0.058
  133. Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: role of VEGF-receptor 2 and host VEGF-A. Cancer Res. 2001 Mar 15; 61(6):2404-8.
    View in: PubMed
    Score: 0.058
  134. Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model. Radiat Oncol. 2021 Mar 04; 16(1):48.
    View in: PubMed
    Score: 0.058
  135. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res. 2000 Nov 15; 60(22):6248-52.
    View in: PubMed
    Score: 0.057
  136. NAD+-mediated rescue of prenatal forebrain angiogenesis restores postnatal behavior. Sci Adv. 2020 10; 6(41).
    View in: PubMed
    Score: 0.056
  137. Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy. Cancer Res. 2000 Aug 15; 60(16):4556-60.
    View in: PubMed
    Score: 0.056
  138. Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines. Cancer Res. 2020 10 15; 80(20):4314-4323.
    View in: PubMed
    Score: 0.055
  139. Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction. Cancer Res. 2000 Apr 15; 60(8):2128-31.
    View in: PubMed
    Score: 0.054
  140. Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapy. Nat Biotechnol. 2020 04; 38(4):420-425.
    View in: PubMed
    Score: 0.054
  141. Cells shed from tumours show reduced clonogenicity, resistance to apoptosis, and in vivo tumorigenicity. Br J Cancer. 1999 Nov; 81(5):756-9.
    View in: PubMed
    Score: 0.053
  142. Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1. Nat Med. 1999 Oct; 5(10):1203-8.
    View in: PubMed
    Score: 0.052
  143. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res. 1999 Aug 15; 59(16):4129-35.
    View in: PubMed
    Score: 0.052
  144. Retraction Note: A homing system targets therapeutic T cells to brain cancer. Nature. 2019 03; 567(7746):132.
    View in: PubMed
    Score: 0.050
  145. In vitro and in vivo quantification of adhesion between leukocytes and vascular endothelium. Methods Mol Med. 1999; 18:553-75.
    View in: PubMed
    Score: 0.050
  146. Tumor induction of VEGF promoter activity in stromal cells. Cell. 1998 Sep 18; 94(6):715-25.
    View in: PubMed
    Score: 0.049
  147. A homing system targets therapeutic T cells to brain cancer. Nature. 2018 09; 561(7723):331-337.
    View in: PubMed
    Score: 0.049
  148. Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis. 2018 08; 21(3):425-532.
    View in: PubMed
    Score: 0.048
  149. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol. 1998 Jul; 111(1):1-6.
    View in: PubMed
    Score: 0.048
  150. Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green. Proc Natl Acad Sci U S A. 2018 04 24; 115(17):4465-4470.
    View in: PubMed
    Score: 0.047
  151. Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity. J Immunol. 2018 04 15; 200(8):3000-3007.
    View in: PubMed
    Score: 0.047
  152. MicroRNA-378 enhances radiation response in ectopic and orthotopic implantation models of glioblastoma. J Neurooncol. 2018 Jan; 136(1):63-71.
    View in: PubMed
    Score: 0.046
  153. Wide-field three-photon excitation in biological samples. Light Sci Appl. 2017 May 05; 6:e16255.
    View in: PubMed
    Score: 0.044
  154. Next-generation in vivo optical imaging with short-wave infrared quantum dots. Nat Biomed Eng. 2017; 1.
    View in: PubMed
    Score: 0.044
  155. Leukocyte-endothelial adhesion and angiogenesis in tumors. Cancer Metastasis Rev. 1996 Jun; 15(2):195-204.
    View in: PubMed
    Score: 0.042
  156. A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer. Sci Transl Med. 2016 Jan 06; 8(320):320ra4.
    View in: PubMed
    Score: 0.040
  157. Mouse embryonic fibroblasts exhibit extensive developmental and phenotypic diversity. Proc Natl Acad Sci U S A. 2016 Jan 05; 113(1):122-7.
    View in: PubMed
    Score: 0.040
  158. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 1995 Sep 01; 55(17):3752-6.
    View in: PubMed
    Score: 0.039
  159. Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen Sensors. J Am Chem Soc. 2015 Aug 12; 137(31):9832-42.
    View in: PubMed
    Score: 0.039
  160. Quantum dot/antibody conjugates for in vivo cytometric imaging in mice. Proc Natl Acad Sci U S A. 2015 Feb 03; 112(5):1350-5.
    View in: PubMed
    Score: 0.038
  161. Correlative intravital imaging of cGMP signals and vasodilation in mice. Front Physiol. 2014; 5:394.
    View in: PubMed
    Score: 0.037
  162. Magneto-fluorescent core-shell supernanoparticles. Nat Commun. 2014 Oct 09; 5:5093.
    View in: PubMed
    Score: 0.037
  163. Transgenic mice for cGMP imaging. Circ Res. 2013 Aug 02; 113(4):365-71.
    View in: PubMed
    Score: 0.034
  164. Compact high-quality CdSe-CdS core-shell nanocrystals with narrow emission linewidths and suppressed blinking. Nat Mater. 2013 May; 12(5):445-51.
    View in: PubMed
    Score: 0.033
  165. Spatial charge configuration regulates nanoparticle transport and binding behavior in vivo. Angew Chem Int Ed Engl. 2013 Jan 28; 52(5):1414-9.
    View in: PubMed
    Score: 0.033
  166. Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy. Proc Natl Acad Sci U S A. 2012 Oct 23; 109(43):17561-6.
    View in: PubMed
    Score: 0.032
  167. Cancer imaging by optical coherence tomography: preclinical progress and clinical potential. Nat Rev Cancer. 2012 Apr 05; 12(5):363-8.
    View in: PubMed
    Score: 0.031
  168. Studying primary tumor-associated fibroblast involvement in cancer metastasis in mice. Nat Protoc. 2012 Mar 22; 7(4):756-62.
    View in: PubMed
    Score: 0.031
  169. Impaired lymphatic contraction associated with immunosuppression. Proc Natl Acad Sci U S A. 2011 Nov 15; 108(46):18784-9.
    View in: PubMed
    Score: 0.030
  170. Engineered blood vessel networks connect to host vasculature via wrapping-and-tapping anastomosis. Blood. 2011 Oct 27; 118(17):4740-9.
    View in: PubMed
    Score: 0.030
  171. PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer. Clin Cancer Res. 2011 Jun 01; 17(11):3638-48.
    View in: PubMed
    Score: 0.029
  172. A nanoparticle size series for in vivo fluorescence imaging. Angew Chem Int Ed Engl. 2010 Nov 08; 49(46):8649-52.
    View in: PubMed
    Score: 0.028
  173. Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks. Nat Methods. 2010 Aug; 7(8):655-60.
    View in: PubMed
    Score: 0.028
  174. In vivo wide-area cellular imaging by side-view endomicroscopy. Nat Methods. 2010 Apr; 7(4):303-5.
    View in: PubMed
    Score: 0.027
  175. InAs(ZnCdS) quantum dots optimized for biological imaging in the near-infrared. J Am Chem Soc. 2010 Jan 20; 132(2):470-1.
    View in: PubMed
    Score: 0.027
  176. Compact biocompatible quantum dots via RAFT-mediated synthesis of imidazole-based random copolymer ligand. J Am Chem Soc. 2010 Jan 20; 132(2):472-83.
    View in: PubMed
    Score: 0.027
  177. Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging. Nat Med. 2009 Oct; 15(10):1219-23.
    View in: PubMed
    Score: 0.026
  178. Feasibility of in vivo imaging of fluorescent proteins using lifetime contrast. Opt Lett. 2009 Jul 01; 34(13):2066-8.
    View in: PubMed
    Score: 0.026
  179. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol. 2007 Mar; 25(3):317-8.
    View in: PubMed
    Score: 0.022
  180. Genetic evidence for a tumor suppressor role of HIF-2alpha. Cancer Cell. 2005 Aug; 8(2):131-41.
    View in: PubMed
    Score: 0.020
  181. Responses to antiangiogenesis treatment of spontaneous autochthonous tumors and their isografts. Cancer Res. 2003 Feb 15; 63(4):747-51.
    View in: PubMed
    Score: 0.017
  182. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Cancer Res. 2002 Dec 01; 62(23):6831-6.
    View in: PubMed
    Score: 0.016
  183. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 1998 Jul 30; 394(6692):485-90.
    View in: PubMed
    Score: 0.012
  184. Mice lacking E-selectin show normal numbers of rolling leukocytes but reduced leukocyte stable arrest on cytokine-activated microvascular endothelium. Microcirculation. 1998; 5(2-3):153-71.
    View in: PubMed
    Score: 0.012
  185. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 1997 May 30; 276(5317):1423-5.
    View in: PubMed
    Score: 0.011
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.